Originally Posted by Bwana:
Once again, don't come in this thread with some kind of political agenda, or you will be shown the door. If you want to go that route, there is a thread about this in DC.
Originally Posted by Dartgod:
People, there is a lot of good information in this thread, let's try to keep the petty bickering to a minimum.
We all have varying opinions about the impact of this, the numbers, etc. We will all never agree with each other. But we can all keep it civil.
Thanks!
Click here for the original OP:
Spoiler!
Apparently the CoronaVirus can survive on a inanimate objects, such as door knobs, for 9 days.
California coronavirus case could be first spread within U.S. community, CDC says
By SOUMYA KARLAMANGLA, JACLYN COSGROVE
FEB. 26, 2020 8:04 PM
The Centers for Disease Control and Prevention is investigating what could be the first case of novel coronavirus in the United States involving a patient in California who neither recently traveled out of the country nor was in contact with someone who did.
“At this time, the patient’s exposure is unknown. It’s possible this could be an instance of community spread of COVID-19, which would be the first time this has happened in the United States,” the CDC said in a statement. “Community spread means spread of an illness for which the source of infection is unknown. It’s also possible, however, that the patient may have been exposed to a returned traveler who was infected.”
The individual is a resident of Solano County and is receiving medical care in Sacramento County, according to the state Department of Public Health.
The CDC said the “case was detected through the U.S. public health system — picked up by astute clinicians.”
Officials at UC Davis Medical Center expanded on what the federal agency might have meant by that in an email sent Wednesday, as reported by the Davis Enterprise newspaper.
The patient arrived at UC Davis Medical Center from another hospital Feb. 19 and “had already been intubated, was on a ventilator, and given droplet protection orders because of an undiagnosed and suspected viral condition,” according to an email sent by UC Davis officials that was obtained by the Davis Enterprise.
The staff at UC Davis requested COVID-19 testing by the CDC, but because the patient didn’t fit the CDC’s existing criteria for the virus, a test wasn’t immediately administered, according to the email. The CDC then ordered the test Sunday, and results were announced Wednesday. Hospital administrators reportedly said in the email that despite these issues, there has been minimal exposure at the hospital because of safety protocols they have in place.
A UC Davis Health spokesperson declined Wednesday evening to share the email with The Times.
Since Feb. 2, more than 8,400 returning travelers from China have entered California, according to the state health department. They have been advised to self-quarantine for 14 days and limit interactions with others as much as possible, officials said.
“This is a new virus, and while we are still learning about it, there is a lot we already know,” Dr. Sonia Angell, director of the California Department of Public Health, said in a statement. “We have been anticipating the potential for such a case in the U.S., and given our close familial, social and business relationships with China, it is not unexpected that the first case in the U.S. would be in California.”
It is not clear how the person became infected, but public health workers could not identify any contacts with people who had traveled to China or other areas where the virus is widespread. That raises concern that the virus is spreading in the United States, creating a challenge for public health officials, experts say.
“It’s the first signal that we could be having silent transmission in the community,” said Lawrence Gostin, director of the World Health Organization Collaborating Center on National and Global Health Law. “It probably means there are many more cases out there, and it probably means this individual has infected others, and now it’s a race to try to find out who that person has infected.”
On Tuesday, the CDC offered its most serious warning to date that the United States should expect and prepare for the coronavirus to become a more widespread health issue.
“Ultimately, we expect we will see coronavirus spread in this country,” said Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases. “It’s not so much a question of if, but a question of when.”
According to the CDC’s latest count Wednesday morning, 59 U.S. residents have tested positive for the new strain of coronavirus — 42 of whom are repatriated citizens from a Diamond Princess cruise. That number has grown by two since Messonnier’s last count Tuesday, although the CDC was not immediately available to offer details on the additional cases.
More than 82,000 cases of coronavirus have been reported globally, and more than 2,700 people have died, with the majority in mainland China, the epicenter of the outbreak.
But public health leaders have repeatedly reminded residents that the health risk from the novel coronavirus to the general public remains low.
“While COVID-19 has a high transmission rate, it has a low mortality rate,” the state Department of Public Health said in a statement Wednesday. “From the international data we have, of those who have tested positive for COVID-19, approximately 80% do not exhibit symptoms that would require hospitalization. There have been no confirmed deaths related to COVID-19 in the United States to date.”
CDC officials have also warned that although the virus is likely to spread in U.S. communities, the flu still poses a greater risk.
Gostin said the news of potential silent transmission does not eliminate the possibility of containing the virus in the U.S. and preventing an outbreak.
“There are few enough cases that we should at least try,” he said. “Most of us are not optimistic that that will be successful, but we’re still in the position to try.”
Moderna said their vaccine is stable for 30 days between 2 and 8 degrees. If true, it's way easier to deal with than the Pfizer vaccine that needs to be kept crazy cold.
I'd been hoping we'd get results from Johnson & Johnson. They started Phase 3 in Sept too. They started a second trial where they're administering two shots. I wonder if that means there early data wasn't great. [Reply]
I really don’t get Fauci saying we could be completely back to normal by next winter. If we have vaccines early in the year for high risk and medical professionals and then the rest in March/April this country should be completely fine by Summer if not earlier. [Reply]
Originally Posted by RunKC:
I really don’t get Fauci saying we could be completely back to normal by next winter. If we have vaccines early in the year for high risk and medical professionals and then the rest in March/April this country should be completely fine by Summer if not earlier.
There’s so many people to vaccinate and if they’ll even get it is another discussion.
It’ll take a while but yeah, once people get vaccinated they’re going back to normal. I sure as shit am.
And I hope I never have to hear about public health again for a while [Reply]
Originally Posted by RunKC:
I really don’t get Fauci saying we could be completely back to normal by next winter. If we have vaccines early in the year for high risk and medical professionals and then the rest in March/April this country should be completely fine by Summer if not earlier.
Dr. Anthony Fauci, the U.S. government’s top infectious-disease expert, said on Sunday that he thinks the U.S. could start getting back to “relative normal” by April or July of 2021, as the coronavirus pandemic continues to grip the nation.
Fauci told CNN’s Jake Tapper on “State of the Union” he thought that would be possible to achieve by the second or third quarter of 2021, but the question of when Americans can safely gather in large groups again depends on a number of factors.
He pointed to Pfizer’s announcement that early data shows the manufacturer’s coronavirus vaccine is more than 90% effective and noted that a second company is expected to soon unveil its early results.
“That’s great, but we have to get people to take the vaccine,” Fauci said.
“So, if we get the overwhelming majority of people taking the vaccine, and you have on the one hand an effective vaccine, on the other hand, a high degree of uptake of the vaccine, we could start getting things back to relative normal as we get into the second and third quarter of the year, where people can start thinking about doing things that were too dangerous just months ago,” Fauci said.
But he added that the country “can’t just wish it happening.”
Vaccines have to come, they must be deployed and fundamental public health measures can’t be abandoned, Fauci stressed.
“You can approach a degree of normality while still doing some fundamental public health things that synergize with the vaccine to get us back to normal,” he said. [Reply]
Originally Posted by RunKC:
I really don’t get Fauci saying we could be completely back to normal by next winter. If we have vaccines early in the year for high risk and medical professionals and then the rest in March/April this country should be completely fine by Summer if not earlier.
Originally Posted by O.city:
There’s so many people to vaccinate and if they’ll even get it is another discussion.
It’ll take a while but yeah, once people get vaccinated they’re going back to normal. I sure as shit am.
And I hope I never have to hear about public health again for a while
And also, this a biggie, if Americans don't take the vaccine, thats an issue.
Anyone know what % of of Americans need to take the vaccine for it it to work? [Reply]
Originally Posted by RunKC:
Recent CDC numbers showed 80% of the deaths from 65+ age group.
Get those people vaccinated first and this thing goes down drastically.
Another question....... Is there a published list of which groups get the vaccine first?
Assumed that health care workers and nursing home patients get it first.
This is great news about Moderna. I will be getting the Moderna vaccine since that is probably what our company will be distributing. I will wait awhile though, maybe until spring time to get it just in case. [Reply]
Originally Posted by BigRedChief:
And also, this a biggie, if Americans don't take the vaccine, thats an issue.
Anyone know what % of of Americans need to take the vaccine for it it to work?
If it works it shouldn't matter.
And has anyone posted the studies done on the GS-441524 component of remdesivir? It's worked really well on cats, rats, and while not as much still effective in monkeys. [Reply]
Originally Posted by :
The primary endpoint of the Phase 3 COVE study is based on the analysis of COVID-19 cases confirmed and adjudicated starting two weeks following the second dose of vaccine. This first interim analysis was based on 95 cases, of which 90 cases of COVID-19 were observed in the placebo group versus 5 cases observed in the mRNA-1273 group, resulting in a point estimate of vaccine efficacy of 94.5% (p <0.0001).
A secondary endpoint analyzed severe cases of COVID-19 and included 11 severe cases (as defined in the study protocol) in this first interim analysis. All 11 cases occurred in the placebo group and none in the mRNA-1273 vaccinated group.
The 95 COVID-19 cases included 15 older adults (ages 65+) and 20 participants identifying as being from diverse communities (including 12 Hispanic or LatinX, 4 Black or African Americans, 3 Asian Americans and 1 multiracial).
The interim analysis included a concurrent review of the available Phase 3 COVE study safety data by the DSMB, which did not report any significant safety concerns. A review of solicited adverse events indicated that the vaccine was generally well tolerated. The majority of adverse events were mild or moderate in severity. Grade 3 (severe) events greater than or equal to 2% in frequency after the first dose included injection site pain (2.7%), and after the second dose included fatigue (9.7%), myalgia (8.9%), arthralgia (5.2%), headache (4.5%), pain (4.1%) and erythema/redness at the injection site (2.0%). These solicited adverse events were generally short-lived. These data are subject to change based on ongoing analysis of further Phase 3 COVE study data and final analysis.
This makes a lot of sense in my case. In my work area all but 3 people out of 15 have gotten it in the last 3 months. I was one that didn't get it.
However last January when I should have been enjoying the playoffs I was sick for 3 weeks and almost went to the hospital. The week before the SB I was coughing up about 10 oz of fluid a day. Looking back it was very Covid like. My old boss and I both think we got it back then and that's why we didn't in the last 6 months or so when everyone else did. [Reply]
Originally Posted by dirk digler:
Side effects seem mild as well.
No way of knowing any long term effects.
That's a trade off people will have to think about and make a decision on. Older people probably won't have to worry about long term effects anyway... [Reply]